Jpmorgan Chase & CO Elanco Animal Health Inc Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 472,364 shares of ELAN stock, worth $8.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

472,364

Previous 7,458,408 93.67%

Holding current value

$8.23 Million

Previous $90.3 Million 94.51%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$10.04 - $12.47 $70.1 Million - $87.1 Million	-6,986,044 Reduced 93.67%	472,364 $4.96 Million
Q4 2024 Feb 12, 2025	SELL	$11.63 - $14.67 $30.2 Million - $38.1 Million	-2,599,248 Reduced 25.84%	7,458,408 $90.3 Million
Q3 2024 Dec 26, 2024	BUY	$11.85 - $15.47 $51.7 Million - $67.5 Million	4,361,799 Added 76.58%	10,057,656 $148 Million
Q3 2024 Nov 08, 2024	BUY	$11.85 - $15.47 $51.7 Million - $67.5 Million	4,361,799 Added 76.58%	10,057,656 $148 Million
Q2 2024 Dec 26, 2024	SELL	$12.93 - $18.45 $56.4 Million - $80.5 Million	-4,361,799 Reduced 43.37%	5,695,857 $82.2 Million
Q2 2024 Aug 12, 2024	SELL	$12.93 - $18.45 $16.9 Million - $24.2 Million	-1,309,246 Reduced 18.69%	5,695,857 $82.2 Million
Q1 2024 Dec 26, 2024	SELL	$14.37 - $16.46 $43.9 Million - $50.2 Million	-3,052,553 Reduced 30.35%	7,005,103 $114 Million
Q1 2024 May 10, 2024	BUY	$14.37 - $16.46 $8.97 Million - $10.3 Million	624,197 Added 9.78%	7,005,103 $114 Million
Q4 2023 Dec 26, 2024	SELL	$8.6 - $14.94 $31.6 Million - $54.9 Million	-3,676,750 Reduced 36.56%	6,380,906 $95.1 Million
Q4 2023 Feb 12, 2024	BUY	$8.6 - $14.94 $9.68 Million - $16.8 Million	1,125,888 Added 21.43%	6,380,906 $95.1 Million
Q3 2023 Nov 14, 2023	BUY	$9.81 - $12.62 $3.18 Million - $4.09 Million	324,308 Added 6.58%	5,255,018 $59.1 Million
Q2 2023 Aug 11, 2023	SELL	$8.08 - $10.37 $49.6 Million - $63.7 Million	-6,143,203 Reduced 55.47%	4,930,710 $49.6 Million
Q1 2023 May 18, 2023	BUY	$8.79 - $14.58 $161,779 - $268,344	18,405 Added 0.17%	11,073,913 $104 Million
Q1 2023 May 11, 2023	BUY	$8.79 - $14.58 $65.9 Million - $109 Million	7,497,967 Added 210.76%	11,055,508 $104 Million
Q4 2022 Feb 13, 2023	BUY	$11.49 - $13.65 $16 Million - $19.1 Million	1,396,140 Added 64.59%	3,557,541 $43.5 Million
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $20.5 Million - $53.7 Million	1,654,968 Added 326.79%	2,161,401 $26.8 Million
Q2 2022 Aug 11, 2022	BUY	$19.63 - $26.62 $2.97 Million - $4.03 Million	151,429 Added 42.66%	506,433 $9.94 Million
Q1 2022 May 11, 2022	BUY	$24.65 - $29.0 $1.18 Million - $1.39 Million	47,881 Added 15.59%	355,004 $9.26 Million
Q4 2021 Feb 10, 2022	BUY	$27.74 - $34.09 $3.76 Million - $4.62 Million	135,470 Added 78.92%	307,123 $8.72 Million
Q3 2021 Nov 12, 2021	BUY	$29.2 - $36.72 $5.01 Million - $6.3 Million	171,653 New	171,653 $5.47 Million

Others Institutions Holding ELAN

# of Institutions

417

Shares Held

487M

Call Options Held

868K

Put Options Held

1.42M

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $8.26B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Elanco Animal Health Inc Transaction History